EUCRW

Eucrates Biomedical Acquisition Corp. Warrant
EUCRW

Overview Fund Activity
Delisted

EUCRW was delisted on the 26th of April, 2023.

Back to rankings

22 hedge funds and large institutions have $731K invested in Eucrates Biomedical Acquisition Corp. Warrant in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 6 closing their positions.

Holders
22
Holders Change
-3
Holders Change %
-12%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
2
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
CAC
1
Cowen and Company
New York
$8.2K
2
KPF
2
K2 Principal Fund
Ontario, Canada
$1.14K
3
Citadel Advisors
3
Citadel Advisors
Florida
$736
4
CS
4
Clear Street
New York
$107
5
Bank of America
5
Bank of America
North Carolina
$7

Top Sellers

1
GPCM
1
Granite Point Capital Management
Massachusetts
$0
2
CH
2
CVI Holdings
Delaware
$1.25K
3
Goldman Sachs
3
Goldman Sachs
New York
$0
4
OMC
4
Old Mission Capital
Illinois
$0
5
PC
5
Periscope Capital
Ontario, Canada
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
PC
26
Periscope Capital
Ontario, Canada
– -$851 -15,300 Closed
UBS Group
27
UBS Group
Switzerland
– -$75 -1,255 Closed
1
2